Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Stomach Disorders
How do you approach H. pylori management in terms of evaluating or testing family members of patients who test positive?
Related Questions
How do you further workup and treat a patient with nausea and weight loss found to have granulomatous gastritis on endoscopic biopsies with a negative workup for sarcoidosis or Crohn's disease?
What new or emerging therapies for autoimmune gastritis are available beyond iron and vitamin B12 replacement?
In a patient with Zieve's Syndrome and alcohol related cirrhosis which antibiotic regimen is safe to treat H. pylori?
How do you approach surveillance of gastric hyperplastic polyps of various sizes?
Is there evidence that certain PPIs provide superior clinical efficacy compared to others in real-world practice?
What clinical features would raise your suspicion for IgG-4 related disease?
What is your endoscopic approach towards laterally spreading colonic lesions that are over 2 cm in size?
In an infant whose mother resumes TNF inhibitor therapy (e.g., adalimumab, infliximab, certolizumab) after delivery and is breastfeeding, do you recommend delaying live vaccinations?
How do you approach HCC screening in patients with advanced fibrosis e.g., F3 on FibroScan?
How would you approach the management of asymptomatic ALT and GGT elevation in an older adult patient with depression with psychosis and without history of hepatitis who recently had dose of quetiapine increased and new initiation of SNRI?